Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NR3C1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
NR3C1 is a gene implicated in neurodegeneration research. Key relationships include: expressed in, interacts with, regulates. Associated with ALS, Als, Alzheimer. Connected to 195 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | NR3C1 |
| Aliases | Glucocorticoid receptor, GR, GCR |
| Chromosome | 5q31.3 |
| Protein Type | Transcription Factor |
| Target Class | Transcription Factor |
| Function | Selective glucocorticoid receptor modulators (SRMs) or antagonists |
| Mechanism of Action | Selective glucocorticoid receptor modulators (SRMs) or antagonists |
| Druggability | Medium (0.53) |
| Clinical Stage | Approved |
| Molecular Weight | 86 kDa |
| Amino Acids | 777 aa |
| Pathways | HPA axis, NF-kB suppression, MAPK signaling, Circadian rhythm |
| UniProt ID | F1D8N4 |
| GeneCards | NR3C1 |
| Human Protein Atlas | NR3C1 |
| Associated Diseases | Addiction, Als, Alzheimer, Alzheimer's disease |
| Known Drugs/Compounds | Corticosterone, Dazucorilant, dexamethasone, Melatonin |
| Interactions | ABCA1, ABCB1, ACAT1, ALZHEIMER, AND, ANXIETY |
| SciDEX Target | View Target Profile (8 clinical trials) |
| KG Connections | 611 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
graph TD
NR3C1["NR3C1"] -->|"associated"| neurodegeneration["neurodegeneration"]
NR3C1["NR3C1"] -->|"interacts"| CRH["CRH"]
NR3C1["NR3C1"] -->|"interacts"| TNFA["TNFA"]
NR3C1["NR3C1"] -->|"co discussed"| DRD2["DRD2"]
NR3C1["NR3C1"] -->|"co discussed"| CHR2["CHR2"]
NR3C1["NR3C1"] -->|"co discussed"| CLOCK["CLOCK"]
CRH_1["CRH"] -->|"interacts"| NR3C1["NR3C1"]
TNFA_2["TNFA"] -->|"interacts"| NR3C1["NR3C1"]
FOXP3["FOXP3"] -->|"co discussed"| NR3C1["NR3C1"]
TNFA_3["TNFA"] -->|"co discussed"| NR3C1["NR3C1"]
style NR3C1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:NR3C1 | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| HPA axis | involved_in | pathway | 0.95 |
| Hypothalamic-Pituitary-Adrenal Axis | regulates | pathway | 0.85 |
| Alzheimer's Disease | associated_with | disease | 0.85 |
| emotional aspects of tinnitus | mediates | phenotype | 0.85 |
| stress response | mediates | process | 0.80 |
| Cognitive Function | involved_in | phenotype | 0.80 |
| HPA_axis | regulates | pathway | 0.80 |
| Alzheimer'S Disease | associated_with | disease | 0.75 |
| Hypothalamic-Pituitary-Adrenal Axis | involved_in | pathway | 0.75 |
| Hypersexual Disorder | biomarker_for | disease | 0.70 |
| Alzheimer's disease | biomarker_for | disease | 0.70 |
| Hypersexual Disorder | associated_with | disease | 0.70 |
| Melatonin | involved_in | drug | 0.70 |
| NF-kB signaling | participates_in | pathway | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| cortex | expressed_in | brain_region | 0.70 |
| epigenetic regulation | participates_in | pathway | 0.70 |
| Ms | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Depression | inhibits | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Anxiety | inhibits | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Depression | regulates | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Hypertension | associated_with | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Ptsd | inhibits | disease | 0.65 |
| Carcinoma | interacts_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| Multiple Sclerosis | interacts_with | disease | 0.65 |
| Myasthenia Gravis | interacts_with | disease | 0.65 |
| Addiction | associated_with | disease | 0.65 |
| Ptsd | associated_with | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:NR3C1 | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| Dazucorilant | targets | drug | 0.90 |
| Haloperidol | upregulates | drug | 0.90 |
| h-1e564178 | targets | hypothesis | 0.90 |
| Corticosterone | binds | compound | 0.85 |
| miR-137-3p | regulates | biomarker | 0.85 |
| FKBP5 | associated_with | gene | 0.80 |
| CRH | associated_with | gene | 0.80 |
| Melatonin | targets | drug | 0.80 |
| DNA | associated_with | gene | 0.70 |
| dexamethasone | regulates | compound | 0.70 |
| CRH | interacts_with | gene | 0.61 |
| TNFA | interacts_with | gene | 0.61 |
| BDNF | associated_with | gene | 0.60 |
| APOPTOSIS | interacts_with | gene | 0.60 |
| DEPRESSION | inhibits | gene | 0.60 |
| SKA2 | associated_with | gene | 0.60 |
| ANXIETY | inhibits | gene | 0.60 |
| CRHBP | interacts_with | gene | 0.60 |
| FKBP5 | interacts_with | gene | 0.60 |
| CRHR1 | interacts_with | gene | 0.60 |
| MIRNAS | inhibits | gene | 0.60 |
| IL-18 | associated_with | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| MIRNAS | associated_with | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| apoptosis | inhibits | pathway | 0.60 |
| RNA | inhibits | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| DEPRESSION | regulates | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| NR3C2 | activates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| DEPRESSION | activates | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| HSA-MIR-181A-5P | associated_with | gene | 0.60 |
| MYC | associated_with | gene | 0.60 |
| NFKB1 | associated_with | gene | 0.60 |
| BDNF | interacts_with | gene | 0.60 |
| ACAT1 | activates | gene | 0.60 |
| LRP1 | associated_with | gene | 0.60 |
| MAPK1 | targets | gene | 0.60 |
| NATURAL COMPOUNDS | associated_with | gene | 0.60 |
| TNF-ALPHA | associated_with | gene | 0.60 |
| ITGB1 | associated_with | gene | 0.60 |
| BACE1 | targets | gene | 0.60 |
| HPA AXIS RELATED GENES | associated_with | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| GSK3B | targets | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.756
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning NR3C1 in their description or question text
No additional research found